Related Experiment Video
Updated: Jan 21, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Aerosolized Antibiotics for Treatment of Pneumonia in Mechanically Ventilated Subjects
Fatima J Wong1, Tina Dudney1, Rajiv Dhand2
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Graduate School of Medicine, University of Tennessee Health Sciences Center Knoxville, Knoxville, Tennessee.
Abstract:
Mechanical ventilation is a well-established and commonly employed modality of treatment for critically ill patients in the ICU. Pneumonia is a frequent complication in mechanically ventilated patients. Patients who develop ventilator-associated pneumonia (VAP) incur higher medical costs, have prolonged ICU and hospital stays, and have increased mortality risk. There is growing interest in finding new treatment modalities for this condition because the success rate for treating VAP with systemic antibiotics continues to be < 70%. Accordingly, clinicians are reevaluating the role of aerosolized antibiotics, either as a sole therapy or as adjuncts to systemic antibiotics, in an attempt to improve clinical outcomes in patients with VAP. There are several clinical settings in which aerosolized antibiotics could be used for treating pneumonia, including their use for prevention, as monotherapy, as adjunctive therapy with systemic antibiotics, and for treatment of extensively drug-resistant or pan drug-resistant pathogens. However, aerosolized antibiotics have not been uniformly effective for improving clinical outcomes of patients with VAP, and local and systemic side effects could complicate their use. Moreover, many questions about aerosolized antibiotics, such as optimal formulations and dosage and treatment regimens, remain unanswered and warrant future investigations.
Insights
Aerosolized antibiotics are being explored to treat ventilator-associated pneumonia (VAP) due to low systemic antibiotic success rates. However, their effectiveness and optimal use remain uncertain, requiring further research.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Pulmonology
Background:
- Ventilator-associated pneumonia (VAP) is a common and costly complication in mechanically ventilated patients.
- Current systemic antibiotic treatments for VAP have a success rate below 70%, prompting the search for alternative therapies.
- Increased mortality, prolonged ICU stays, and higher medical costs are associated with VAP.
Purpose of the Study:
- To evaluate the potential of aerosolized antibiotics as a treatment modality for VAP.
- To explore the use of aerosolized antibiotics as monotherapy or adjunct therapy to systemic antibiotics.
- To identify optimal formulations, dosages, and treatment regimens for aerosolized antibiotic therapy in VAP.
Main Methods:
- Review of existing clinical data and research on aerosolized antibiotic use in VAP.
- Analysis of potential benefits and drawbacks of aerosolized antibiotic administration.
- Identification of knowledge gaps and areas for future investigation.
Main Results:
- Aerosolized antibiotics show promise but have not consistently improved clinical outcomes in VAP.
- Potential applications include prevention, monotherapy, adjunctive therapy, and treatment of drug-resistant pathogens.
- Local and systemic side effects can complicate the use of aerosolized antibiotics.
Conclusions:
- Further research is needed to establish the efficacy and safety of aerosolized antibiotics for VAP.
- Optimal dosing, formulations, and treatment strategies require further investigation.
- Aerosolized antibiotics may offer a valuable therapeutic option for VAP, particularly for drug-resistant infections.
Related Concept Videos
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation I: Indication and Settings
Antibiotic Selection
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology

